Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516539 | SCV000615213 | benign | not specified | 2020-11-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000531955 | SCV000645289 | likely benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2024-09-05 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001509372 | SCV001716036 | uncertain significance | not provided | 2021-06-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001509372 | SCV001776705 | uncertain significance | not provided | 2024-10-21 | criteria provided, single submitter | clinical testing | Observed in a child with cleft lip and palate who also harbored additional variants in genes related to the phenotype (PMID: 35385219); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 35385219) |
Ambry Genetics | RCV002395238 | SCV002672706 | uncertain significance | Inborn genetic diseases | 2020-11-25 | criteria provided, single submitter | clinical testing | The p.S2497N variant (also known as c.7490G>A), located in coding exon 24 of the SETX gene, results from a G to A substitution at nucleotide position 7490. The serine at codon 2497 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the supporting evidence, this variant is unlikely to be causative of autosomal dominant juvenile amyotrophic lateral sclerosis 4; however, its contribution to the development of autosomal recessive spinocerebellar ataxia with axonal neuropathy 2 is uncertain. |
Prevention |
RCV004541622 | SCV004774721 | likely benign | SETX-related disorder | 2022-11-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |